--To the press -
FRONTEO AI Innovation Forum 2023 held
Deliverables created by AI play an important role in society's supply chain
FRONTEO Inc.
Masahiro Morimoto, President and CEO
2-12-23 Konan, Minato-ku, Tokyo
(Code number: 2158 TSE Growth)
FRONTEO Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter referred to as FRONTEO) will hold an event called "FRONTEO AI Innovation Forum 2023” will be held.
The FRONTEO AI Innovation Forum is a private conference hosted by FRONTEO, which is now in its fifth year.This conference will develop in the fields of evolution of the innovative natural language processing AI "KIBIT" developed by FRONTEO, international litigation/forensics, drug discovery support/life science, business DX, and economic security. We have introduced the transformation of companies that have introduced KIBIT-equipped solutions.
This time, the 5th time, we will introduce the AI Factory concept that FRONTEO is promoting from the drug discovery support service, and at the same time, the deliverables produced by AI and experts with deep knowledge in each field will be important supply chains in society. We will inform you through keynote speeches by experts and the latest trends in solving business and management issues of companies that have introduced KIBIT-equipped solutions.
【Webinar Summary】
Time & Date | July 2023, 7 (Wednesday) 19: 11-00: 18 (00:10 opening / reception start) |
Held format | Held onsite (simultaneously held online) |
Official website | |
How to apply for participation | Pre-registration from the official website (free) |
* The latest information will be posted on the official website at any time.
[Program speakers (partial introduction)]
<Keynote Speech>
Mr. Mitsunobu Koshiba: Honorary Chairman of JSR Corporation, Co-Founder of Cdots LLC
Yukio Osawa: Professor, Graduate School of Engineering, The University of Tokyo
<Lectures by area>
International litigation
Mr. Paul Marston: Hughes Hubbard & Reed Head of Tokyo office
Drug discovery support and life science fields
Mr. Ryuta Saito: Chief Researcher, Discovery Research Laboratories, Discovery Research Division, Mitsubishi Tanabe Pharma Corporation
Masayuki Murata: Institute of Innovative Research, Tokyo Institute of Technology
Collaborative Research Center for Multimodal Cellular Analysis Center Director (Specially Appointed Professor)
Business DX field
Mr. Shinji Hirakane: Information Infrastructure Group Manager, Float Technology Promotion Department, Technology Headquarters, AGC Inc.
economic security field
Nobukatsu Kanehara: Special Visiting Professor, Faculty of Law, Graduate School of Law, Doshisha University, Former Deputy Director General of the National Security Agency
In addition to the above people, we plan to have multiple speakers with specialized knowledge in each area.
At this conference, in addition to keynote speeches and lectures by area, FRONTEO's latest AI solutions will be demonstrated at the venue, allowing you to experience today's business problem solving with AI throughout the day.
Through this conference, FRONTEO will disseminate the latest information to everyone who faces business issues with a view to creating a better future, promote the concept of becoming an AI factory, and create a framework for social implementation of each of the deliverables brought about by AI. We will fulfill our responsibilities.
■ About FRONTEO URL: https://www.fronteo.com/
FRONTEO is a data analysis company that provides various AI solutions and services using the in-house developed AI engine "KIBIT". Based on the philosophy of "providing solutions that do not overlook risks and opportunities buried in records and realizing fairness in the information society," extract meaningful and important information from vast amounts of text data and complex networks. Our strengths are natural language processing and network analysis technologies that support the advanced judgment of experts.We are developing businesses in the areas of legal tech AI, business intelligence, life science AI, and economic security, and contributing to solving various corporate and social issues. Founded in August 2003, listed on Tokyo Stock Exchange Mothers (currently Tokyo Stock Exchange Growth) on June 8, 2007.The company operates in Japan, the United States, South Korea, and Taiwan.Acquisition of first-class medical device manufacturing and sales business license, notification of controlled medical device sales business.Capital 6 thousand yen (as of March 26, 3,042,317).
* FRONTEO and KIBIT are registered trademarks of FRONTEO in Japan.
<Contact information for the press>
Public Relations Officer, FRONTEO Inc.
Email: pr_contact@fronteo.com